Fewer Major CVD Events Expected As HTN Management Improves

This article originally appeared here.
Fewer Major CVD Events Expected As HTN Management Improves
Fewer Major CVD Events Expected As HTN Management Improves

(HealthDay News) — Annual surveys show progressive improvements in the management of blood pressure in the general population in England, which will correlate with reduction in major cardiovascular events, according to research published in a May 31 special themed issue of The Lancet. The issue precedes Hypertension 2014, the Joint Meeting of the European Society of Hypertension and International Society of Hypertension, to be held from June 13–16 in Athens.

Emanuela Falaschetti, of the Imperial College London, and colleagues conducted a serial cross-sectional study of five Health Survey for England surveys of adults aged ≥16 years to assess changes in blood pressure management between 1994–2011.

The researchers found progressive improvements in the mean blood pressures of men and women in the general population, as well as for patients with hypertension. Among patients with treated hypertension, mean blood pressure was reduced from 150.0 (standard error [SE], 0.59)/80.2 (SE, 0.27) mm Hg to 135.4 (SE, 0.58)/73.5 (SE, 0.41) mm Hg. During the study period, prevalence of control of blood pressure among treated patients increased from 33% (SE, 1.4%) in 1994 to 63% (SE, 1.7%) in 2011. However, in 2011, hypertension was controlled in only 37% of adults with survey-defined hypertension.

"If the same systematic improvement in all aspects of hypertension management continues until 2022, 80% of patients with treated hypertension will have controlled blood pressure levels with a potential annual saving of about 50,000 major cardiovascular events," the authors write.

One author disclosed financial ties to pharmaceutical companies.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Comment (subscription or payment may be required)